Phase II study of mitomycin-C, adriamycin, cisplatin (MAP) and Bleomycin-CCNU in patients with advanced cancer of the anal canal: An eastern cooperative oncology group study E7282

Author： Jhawer Minaxi   Mani Sridhar   Lefkopoulou Myrto   Hahn Richard   Harris Jules   Catalano Paul   Haller Daniel  

Publisher： Springer Publishing Company

ISSN： 0167-6997

Source： Investigational New Drugs, Vol.24, Iss.5, 2006-09, pp. : 447-454

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Phase II Study of Interferon Gamma in Malignant Carcinoid Tumors (E9292): A Trial of the Eastern Cooperative Oncology Group

By Stuart Keith   Levy Donna E.   Anderson Tom   Axiotis Constantine A.   Dutcher Janice P.   Eisenberg Andrew   Erban John K.   Benson III Al Bowen  

Investigational New Drugs, Vol. 22, Iss. 1, 2004-01 ,pp. : 75-81

Springer Publishing Company

Access to resources Recommend Favorite

Phase II trial of R115777 (NSC #70818) in patients with advanced colorectal cancer: A Southwest Oncology Group study

By Whitehead Robert   McCoy Sheryl   Macdonald John   Rivkin Saul   Neubauer Marcus   Dakhil Shaker   Lenz Heinz-Josef   Tanaka Michael   Abbruzzese James  

Investigational New Drugs, Vol. 24, Iss. 4, 2006-07 ,pp. : 335-341

Springer Publishing Company

Access to resources Recommend Favorite

Phase II study of amrubicin, 9-amino-anthracycline, in patients with advanced non-small-cell lung cancer: a West Japan Thoracic Oncology Group (WJTOG) study

By Takeda Koji   Takifuji Nobuhide   Negoro Shunichi   Furuse Kiyoyuki   Nakamura Shinichiro   Takada Yoshiki   Hoso Takanobu   Hayasaka Shinichi   Nakano Takashi   Araki Jun   Senba Hiroshi   Iwami Fumiyuki   Yamaji Yasufumi   Fukuoka Masahiro   Ikegami Harumichi  

Investigational New Drugs, Vol. 25, Iss. 4, 2007-08 ,pp. : 377-383

Springer Publishing Company

Access to resources Recommend Favorite

Multicenter phase II study of amrubicin, 9-amino-anthracycline, in patients with advanced non-small-cell lung cancer (Study 1): West Japan Thoracic Oncology Group (WJTOG) trial

By Sawa Toshiyuki   Yana Takashi   Takada Minoru   Sugiura Takahiko   Kudoh Shinzoh   Kamei Tadashi   Isobe Takeshi   Yamamoto Hidehiko   Yokota Soichiro   Katakami Nobuyuki   Tohda Yuji   Kawakami Akira   Nakanishi Yoichi   Ariyoshi Yutaka  

Investigational New Drugs, Vol. 24, Iss. 2, 2006-03 ,pp. : 151-158

Springer Publishing Company

Access to resources Recommend Favorite

A Phase II study of celecoxib, gemcitabine, and cisplatin in advanced pancreatic cancer

By El-Rayes Basil   Zalupski Mark   Shields Anthony   Ferris Ann   Vaishampayan Ulka   Heilbrun Lance   Venkatramanamoorthy Raghu   Adsay Volkan   Philip Philip  

Investigational New Drugs, Vol. 23, Iss. 6, 2005-12 ,pp. : 583-590

Springer Publishing Company

Access to resources Recommend Favorite